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Abstract
Background: This study is an investigation as to whether salivary amylase secretory rates are correlated with the
magnitude of postprandial glycaemic responses to starch ingestion in healthy young Malaysian adults.
Methods: Fasting unstimulated and stimulated salivary amylase secretory rates were measured and ranked for 54
participants. Subjects (n = 5) with amylase activities below the median and subjects (n = 5) with amylase activities
above the median were selected for subsequent carbohydrate challenge tests. Following an overnight fast, the
postprandial glycaemic responses of these subjects were assessed to 50 g carbohydrate bolus challenges; glucose
(n = 2), maltose (n = 1) and starch (n = 1), tested in random order. Blood glucose concentrations were estimated
before each carbohydrate challenge and at half-hour intervals thereafter for 2 h. The magnitude of each glycaemic
response was estimated from the area under the curve (AUC).
Results: High amylase secretors responded to the consumption of a starch bolus with significantly lower AUCs
than low amylase secretors (267 +/− 64 vs. 159 +/− 72 mmol/L*120 min, p = 0.037; mean +/− SD). However, the
glycaemic responses to maltose and glucose did not differ significantly between the two groups. These findings
confirm that subjects with higher salivary amylase secretory rates have better glycaemic tolerance to a starch
challenge than subjects with lower salivary amylase secretory rates.
Conclusion: Low amylase secretion should be considered as a potential prognosticator for impaired glucose
tolerance to dietary starch in young Malaysian adults.
Keywords: Salivary α-amylase, Glycaemic response, Starch, Glucose, Maltose, Gastric inhibitory peptide
Background
Impaired glucose tolerance (IGT) is an asymptomatic
condition, which precedes the development of type II
diabetes [1]. The early detection of IGT would facilitate
advocacy of life-style changes and other measures to re-
duce or delay its potentially morbid sequel. Development
of a rapid, simple, reliable and inexpensive test for IGT
would enhance the process of detection and treatment
of IGT in the population and thereby potentially im-
prove health outcomes. The problem of impaired glu-
cose tolerance is particularly relevant to East Asians,
because it has recently been shown that glycaemic
responses, whether to starch or glucose, are generally
greater in Chinese than in Europeans [2], raising the
possibility that this may apply to Malaysians, who com-
prised out study cohort.
Because of its facile and non-invasive acquisition,
saliva is a promising biological fluid for analysis of bio-
markers of relevance to the early diagnosis, prognosis
and post-therapeutic monitoring of IGT [3].
Saliva contains the enzyme α-amylase. This enzyme is
important for the process of starch digestion, because it
has long been established that swallowing a starch meal
without premixing it effectively with saliva leads to a
generally lower glycemic response [4]. While a 2013
study showed no significant correlation between salivary
amylase and glycaemic response to starch [2], a study by
Mandel et al. 2014 has shown counterintuitively that
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subjects who are high salivary amylase producers, have a
better glucose tolerance to starch than subjects who are
low salivary amylase producers [5]. A coherent explan-
ation for this finding is not readily apparent. In general,
a high salivary amylase activity would be expected to
correlate with a high postprandial glycaemic response,
because salivary amylase is initially responsible for the
generation of maltose from ingested starch. This is then
hydrolysed to two glucose residues by three intestinal
alpha-glucosidases anchored to the mucosal surface of the
small intestine: alpha-glucoamylase, a maltase-isomaltase
and a maltase-sucrase [6]. Glucose is then imported across
the microvillar membranes of the epithelial mucosal lining
of the small intestine by a 2Na+/glucose symporter [7] and
exported to the extracellular fluid by means of glut 2 [8].
The density of expression of symporters on the enterocyte
plasma membrane is recognised as a limiting factor for
glucose transport into plasma [8].
One potential hypothesis that could account for the ap-
parent correlation between high salivary amylase secretory
rates and a low glycaemic response to starch is that mal-
tose, the main initial product of digestion of starch by
salivary amylase, might competitively inhibit glucose
transport by the route described above. Alternatively, a
maltose-induced gastrointestinal endocrine response that
lead to down-regulation of the expression of one or more
or the maltose-hydrolysing alpha-glucosidases, or the
rate-limiting 2Na+/glucose symporter, might indirectly
lead to a reduction in the rate of glucose transport from
the intestinal lumen to portal blood, resulting in a lower
glycaemic response.
The rates of secretion of amylase in saliva of healthy
Malaysian adults and their correlation with glucose tol-
erance/intolerance were investigated in this present
study. The relationship between salivary amylase activity
and glycaemic response to starch has not been under-
taken in SE Asian subjects. In earlier reports of this
topic, the participants were Americans [5] or South
Americans [9], both (presumably) largely of European
origin. E Asians generally consume a diet rich in rice
and have a higher prevalence of glucose intolerance then
is evident in people of European origin [2, 10]. To get
insight into whether maltose might inhibit glucose
transport from the intestinal lumen, in addition to
starch, we investigated the glycaemic response to maltose
in Malaysian high and low salivary amylase secretors. The
main aims of this study were therefore to determine saliv-
ary amylase secretory rates and concentrations in healthy
Malaysian adults, and then to investigate the relationship
between amylase secretory rates and postprandial gly-
caemic responses to starch and maltose ingestion.
The relative proportions of amylopectin and amylose
have an effect on the digestibility of starch. The highly
branched nature of amylopectin allows for a much higher
rate of amylolytic activity compared to amylose. There-
fore, starch with higher amylopectin content will be
digested faster than starch with a higher amylose content
[11, 12]. In the present study we used white bread as a
source of starch. White bread contains wheat with a very
high amylopectin content and very little amylose [13].
Methods
This study, including the experimental details, protocols
and informed consent, received research funding and
ethical approval from the Joint Committee of Ethics and
Research of International Medical University (IMU):
approval no. 4.18/JCM-84/2014.
Subjects
Informed consent was obtained from all participants
prior to screening. Fifty four eligible Malaysian subjects
participated in this study. The majority were students
and staff of IMU. Inclusion criteria were: ages from
18 to 30 years; and body mass indices (BMIs) be-
tween 18 and 27.4 Kg/m2, as specified for non-obese
in the Malaysian Clinical Practice Guidelines, 2004.
Exclusion criteria were: a history of diabetes; pregnancy;
current smokers; and subjects with an illness (or using
medication) known to affect salivary amylase secretion
(including the use of orthodontic devices).
Salivary amylase estimation
A chromogenic kinetic reaction assay kit (1–1902;
Salimetrics In, USA) was used to determine the activity
of amylase in saliva samples. The enzymatic substrate in
this kit was 2-chloro-p-nitrophenol coupled to malto-
triose. Salivary amylase releases 2-chloro-p-nitrophenol
from this substrate, which was then determined from its
Abs405nm. Volumes of saliva, standards and reagents
were all half the volumes recommended in the brochure
supplied with the kit.
Study protocol
Each participant fasted overnight for a minimum of 8 h.
To minimise circadian variability in the salivary secretory
rates, saliva collection was undertaken between 7 a.m. and
9 a.m. on the following morning, After rinsing the mouth
with water (to reduce contamination of the collected sam-
ple with solid particulates) each subject’s non-stimulated
saliva sample was collected in a weighed polypropylene
tube by the passive drool method [5] for exactly 2 min.
Subsequently a stimulated saliva sample was collected for
2 min in a similar manner. The stimulus was 2 % (w/v)
acetic acid, applied at the dorsum of the tongue, using
a cotton tip [14]. After reweighing tubes to determine
the salivary flow rate, the samples were centrifuged at
2000 x g for 10 min at 4 °C, then stored in aliquots of
100 μL at −20 °C for future analysis.
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For determination of amylase activities, samples were
thawed completely, mixed, centrifuged at 3000 rpm for
15 min at 37 °C, and then diluted 200-fold in the diluent
provided in the assay kit. Fixed volumes (4 μL) of con-
trols, standards and diluted saliva samples were added in
replicates of 3 to wells of a 96 well plate. 160 μL of the
α-amylase substrate solution was added to each well and
the plate was immediately placed in a microplate reader,
which was maintained at 37 °C throughout the incuba-
tion. The reader was programmed to read Abs405nm at
1 min and at 3 min. The readings at 1 min were
subtracted from the readings at 3 min. The resulting in-
creases in absorbance provided a measure of the relative
rate of salivary amylase activities. An in-house control
saliva sample, also assayed in replicates of 3, was in-
cluded in each assay, to normalize the results for any
systematic inter-assay variability. The amylase activities
of high and low activity standards with known amylase
concentrations that were provided in the kit, were used
to calibrate the enzyme activity of the in-house standard
control. Then the absolute enzyme activities of the un-
known samples were calculated by comparison with the
in-house control sample, and expressed as U/mL.
Determination of glycaemic responses
The 54 subjects were ranked for their fasting and stimu-
lated salivary amylase activities and averages of the
resulting ranking coefficients were calculated. The high-
est and lowest ranked subjects were invited to further
participate in the glycaemic response tests of this study.
Some subjects were unable or unwilling to participate in
this second phase. Consequently more medially ranked
subjects were recruited in sequence of their ranking
(high or low). Eventually, five in the low activity group
and five in the high amylase activity group were available
for comparing the glycaemic response to starch. The
two experimental test foods comprised starch in 101.8 g
of white bread (served with 200 mL water) and maltose
in 62.5 g of rice malt syrup diluted with 200 mL water.
These test foods each contained equivalent contents of
hexose monomer, taking account of the relative equiva-
lent monomer molecular weights of 168 for starch, 174
for maltose and 180 for glucose. A control glucose
tolerance test using 55.6 g of glucose powder (Glucolin
glucose supplement) dissolved in 200 mL of water was
administered twice to each subject.
Glycaemic responses were tested on participants in the
morning after an 8-h overnight fast. Participants re-
ceived the test and control carbohydrates, in random
order, with a minimum washout between each bolus of
4 days.
During the test with bread as the source of starch,
each participant was requested to chew this and to swal-
low it over 15 min, together with 200 mL of water,
which assisted ingestion. When subjects consumed one
of the sugar solutions, they were advised to swish this
thoroughly in their mouths, to mix it well with saliva,
before drinking it at a constant rate over 15 min. Blood
glucose levels were measured using the finger-prick
method with a glucometer (Freestyle Optium gluc-
ometer, Abbott), immediately before consuming the test
food, and at 15, 30, 45, 60, 90 and 120 min thereafter.
Sample size calculation
With the statistical level of significance set at 5 % and
power at 80 %, 31 subjects were required, in order to
evaluate the averaged salivary amylase with a desired
precision of 4 U/mL, assuming a standard deviation of
11 U/mL [5]. 50 subjects were recruited for sampling in
order to account for potentially incomplete data.
Four subjects in the high amylase secretor group and
four subjects in the low amylase secretor group were re-
quired to detect a difference of 112 mmol/L*120 min in
AUC between the 2 groups with a standard deviation of
55 mmol/L*120 min as determined in Mandel’s study
[6]. To account for a possible drop-out, 5 subjects were
recruited in each group.
Statistical analysis
Statistical analysis was carried out using SPSS Statistics
version 18 (IBM, New York, US). Descriptive statistics
were used to present the data mean and standard
deviation. Comparisons between subjects in the low and
high amylase groups were performed using a Mann
Whitney test or Student T-test, as appropriate.
Results
Characteristics of the experimental population
The experimental population comprised 47 female and 7
male participants, aged from 18 to 29 years and with
BMIs between 18 and 26 Kg/m2. Twenty-nine (~54 %)
had a family history of diabetes and 25 did not. 38
(~70 %), were ethnically Chinese; 10 (~19 %) were
Indian; and 6 (~10 %) were Malay.
Salivary amylase activities
Salivary flow rates were determined on fasted subjects
in both unstimulated and stimulated states. The un-
stimulated flow-rates ranged from 0.09 mL/min to
1.56 mL/min, and the stimulated flow-rates ranged
from 0.15 mL/min to 1.63 mL/min. The salivary amylase
activities in the unstimulated saliva samples ranged from
4.5 U/mL to 94.6 U/mL and the stimulated samples from
1.4 U/mL to 96.6 U/mL. Figure 1 shows the frequency dis-
tribution of these activities. Both non-stimulated and stim-
ulated salivary amylase secretory rates of the 54 subjects
were clearly skewed in their distributions, and from ap-
propriate statistical tests were found not to be normally
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distributed, so values were computed as median (inter-
quartile range). A summary of the salivary secretory rates
and activities for unstimulated and stimulated salivary
amylase activities are presented in Table 1.
As the subjects with and without a family history of
diabetes mellitus (FHDM) were similar in numbers, the
potential association of FHDM with salivary amylase ac-
tivity was assessed. The results are presented in Table 2.
It will be seen from this table that the amylase levels of
subjects without a FHDM was slightly higher than those
with a FHDM. Because of the limited numbers of partic-
ipants, however, this study was not powered to detect
the significance of this difference.
The variation between subjects’ non-stimulated and
stimulated amylase activities are presented in Fig. 2.
While these were highly correlated [r = 0.77 (p < 0.001)],
the non-stimulated and stimulated amylase activities of
several subjects diverged substantially from the trend
Fig. 1 Frequency distributions of the unstimulated (upper graph) and stimulated (lower graph) salivary amylase activities of overnight-fasted subjects
Table 1 Values for the salivary secretory rates and activities for
unstimulated and stimulated saliva flow (n = 54)
Saliva characteristics Unstimulated samples Stimulated samples
Median (IQR) Median (IQR)
Salivary flow-rate (mL/min) 0.51 (0.34) 0.65 (0.39)
Salivary amylase activity (U/mL) 19.7 (20.6) 29.3 (29.3)
Salivary amylase secretory rate (U/min) 12.9 (12.4) 18.2 (12.4)
Table 2 The relationship between a family history of diabetes
mellitus (FHDM) and salivary amylase activities
Group With FHDM Without FHDM p-value
(n = 25) (n = 29)
Unstimulated samples 17.0 (36) U/mL 21.1 (16) U/mL 0.684
Stimulated samples 23.7 (31) U/mL 31.1 (25) U/mL 0.344
Values are analysed using a Mann Whitney U test and are presented as
median (interquartile range)
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line. For those subjects, the appropriate selection cri-
terion for inclusion in a high- or low- amylase group
was equivocal. Accordingly, all subjects were ranked
according to both stimulated and unstimulated amyl-
ase concentrations, and final ranking positions were
established from the average of both ranking coeffi-
cients. The resulting ranking positions for the 10 sub-
jects who were in the high and low amylase groups,
and then agreed to participate in the carbohydrate
tolerance tests, are presented in Table 3. The aver-
aged ranking position of the cohort with low salivary
amylase activity (LA subjects) was 12.8/54, while that
of the cohort with high amylase activity (HA subjects)
was 50.9/54.
There was no correlation between salivary flow-rate and
amylase activity in the fasting (r = −0.063, p = 0.649) or
unstimulated (r = −0.100, p = 0.472) states. Therefore, a
physiological compensation for low salivary amylase activ-
ity with increased salivary flow rate, or a low salivary flow
with increased amylase activity was not observed.
When the socio-demographic characteristics, BMIs
and salivary amylase secretion of these subjects were
compared, the subjects in the low and high amylase
groups showed a highly significant difference in the
average unstimulated and stimulated salivary amylase
activities by which they were ranked, and also in salivary
amylase secretory rates, but not in any other socio-
demographic characteristics. However the disparity in
BMI between the groups was 4 Kg/m2 (p = 0.076) and it
is hard to dismiss this, despite the lack of statistical
significance. Selected aspects of this comparison are pre-
sented in Table 4.
Glycaemic responses of the high (HA) and low amylase
(LA) subject groups in carbohydrate tolerance tests
Subjects were fasted overnight and the studies were
undertaken on the following morning. Glycaemic re-
sponses of the HA and LA subjects to starch, maltose and
glucose test foods are presented in Fig. 3. The areas under
the curves (AUCs) were extrapolated from the glycaemic
profiles and analysed for differences. The analysis is pre-
sented in Table 5. These results clearly showed that the
postprandial glycaemic responses to glucose and maltose
were not significantly different between the LA and HA
groups. In contrast, the response to starch was signifi-
cantly different between the groups. Interestingly, the gly-
caemic response to starch was significantly lower in the
HA group than in the LA group.
Discussion
The findings of the present study have confirmed in
Malaysian subjects the results of the study by Mandel et al.
Fig. 2 The relationship between unstimulated and stimulated salivary amylase activities of all 54 subjects
Table 3 Ranking positions of the 10 subjects who were
selected for, and participated in, the tolerance tests
Cohort with low salivary amylase activity (LA)






M01 1 3 2
M16 2 6 4
M07 12 8 10
M09 27 16 21.5
M31 34 19 26.5
Average 12.8
Cohort with high salivary amylase activity (HA)
M23 44 54 49
M08 51 48 49.5
M17 50 53 51.5
M04 54 50 52
M18 53 52 52.5
Average 50.9
Legend: As several of the highest and lowest ranked subjects were unavailable
for participation in this phase of the study, additionally more medially ranked
subjects were recruited as listed above
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with North American subjects [5] which have shown
that the cohort who are high salivary amylase pro-
ducers, have an improved glucose tolerance to starch
(i.e. lower AUC) compared to subjects who are low sal-
ivary amylase producers. Moreover, it has recently been
shown that there is a negative correlation between sal-
ivary amylase activity and glycaemic response following
starch consumption [9]. Salivary amylase is encoded by
the AMY1 gene. The AMY1 gene is expressed in a wide
range of diploid copy numbers (2–18) in different indi-
viduals and this expression has been conclusively
shown to be highly positively correlated with salivary
amylase concentration in those individuals [15]. That
same study has suggested that individuals from popula-
tions with a long prehistory of agriculture leading to
consumption of high-starch diets have on average more
AMY1 copies than individuals from populations who
historically consumed low-starch diets. Moreover indi-
viduals from populations consuming an almost entirely
starch diet secrete much more salivary amylase than
individuals consuming a low starch diet, with those
consuming a more typical mixed diet having an inter-
mediate level of salivary amylase secretion [16, 17].
Hence there is a correlation between dietary factors
and genetic factors, with both tending to ensure that
dietary consumption of starch is accompanied by high
levels of salivary amylase, suggesting that salivary amyl-
ase secretion is of importance for starch digestion [4].
However, a ready explanation for the clear difference
in glycaemic response to starch between HA and LA
subjects is not apparent. It would seem intrinsically
more likely to have anticipated the opposite outcome to
the one we observed – namely that a high level of
amylase should have resulted in more rapid degradation
of the starch bolus, and that this would have given
higher blood glucose levels than expected to occur in
subjects who were low amylase salivary secretors. One
possible explanation for the anomaly which can be elimi-
nated from further consideration is that our result was
caused by maltose inhibiting glucose uptake or transport
from mucosal cells to serosal extracellular fluid. In that
event, the glycaemic response to maltose would be ex-
pected to be lesser than the glycaemic response to an
equivalent bolus of glucose. As is clearly evident from
the lower graph of Fig. 3, this was not the case.
It is well-recognised that, in response to saccharides in
the gastrointestinal tract, there is an “incretin” response,
involving the secretion of endocrine signalling peptides,
which then induce insulin secretion. Two of the best
characterised of these endocrine signalling peptides
which simulate the beta-cell insulin response to a rise in
plasma [glucose], are gastric inhibitory polypeptide
(GIP) and glucagon-like peptide 1 (GLP-1), released re-
spectively from the mucosal epithelial cells in the upper
part of the small intestine and intestinal L-cells in the
ileum and large intestine. One mechanism for release of
incretin peptides is through (presumed) neural mecha-
nisms activated by the presence of sweet-tasting food in
the mouth. Another non-neural mechanism involves
stimulation of the SGLT1 sodium glucose co-transporter
by one or more saccharides (glucose or maltose) in the
gastrointestinal tract [18, 19]. Maltose has also been
shown to stimulate the release of GIP in in vitro studies
using a perfused rat intestine preparation [20]. Starch is
not sweet, and following a starch bolus, most GIP will
be released by the latter mechanism, activated after sal-
ivary amylase has undertaken its hydrolytic activity, but
before the bolus has been acted on by pancreatic amyl-
ase. GIP strongly potentiates insulin secretion, and its
secretion from the proximal small intestine will result in
an early release of insulin, followed by a prompt de-
crease in blood glucose in the extracellular fluid.
An attractive hypothesis to explain our present data
suggesting that there is a reduced glycaemic response to
starch in high salivary amylase secretors, is that the high
level of salivary amylase secreted by HA subjects will in-
duce an early and substantial rise in saccharide presence
in the proximal part of the small intestine, that will initi-
ate a rapid “incretin” response, mediated via GIP secre-
tion. This in turn will induce a more rapid insulin
response, as observed previously by Mandel [5]. In con-
trast, LA subjects will not experience as great a concen-
tration of saccharide in the proximal small intestine, but
will instead hydrolyse a considerable proportion of their
ingested starch through the activity of pancreatic amyl-
ase. The resulting saccharides will be mostly generated
later, to induce a delayed “incretin” response mediated
Table 4 A comparison between subjects in the low and high
amylase groups (HA vs. LA) using a Mann Whitney test
LA group HA group P value
n = 5 n = 5
BMI (Kg/m2) 24.7 (4.8) 19.5 (4.3) 0.076
Age (years) 22 (4) 22 (3.5) 0.585
Prevalence of family history
of diabetes
4 (80 %) 3 (60 %) 1.000
Fasting salivary flow rate
(mL/min)
0.67 ± 0.39 0.44 ± 0.17 0.271
Fasting salivary amylase
activity (U/mL)
13.10 ± 9.0 69.56 ± 21.3 0.001
Fasting salivary amylase
secretory rate (U/min)
9.45 ± 6.95 31.72 ± 15.4 0.018
Stimulated salivary flow
rate (mL/min)
0.81 ± 0.39 0.59 ± 0.20 0.287
Stimulated salivary amylase
activity (U/mL)
14.68 ± 6.69 78.0 ± 18.1 0.001
Stimulated salivary amylase
secretory rate (U/min)
12.2 ± 6.9 46.7 ± 22.0 0.01
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via GLP-1, secreted from the L-cells of the distal small
intestine. This concept is presented diagrammatically in
Fig. 4. However, GIP is only one of many potential GI
hormones which could be candidates with a trophic
activation of salivary gland amylase secretion. Clearly
much more work is required to confirm or refute this
explanation for our data. These additional studies
could include the measurement of potential incretins
and insulin in serial plasma samples from high- and
low- salivary amylase secretors after ingesting a stand-
ard starch meal.
It is tempting to hypothesise that a prompt output of
GIP might also serve to be a long-term stimulator of
amylase secretion. Indeed, there is evidence that GIP
stimulates the release of pancreatic amylase [21]. So it is
feasible that GIP may also trophically stimulate the pro-
duction and secretion of salivary amylase. If this were so,
the habitual consumption of diets which are high in
starch would result in a large release of GIP, which
would in turn further stimulate salivary amylase produc-
tion. Consumers of high-starch diets from such genetic-
ally or environmentally adapted groups would be
anticipated to be substantially protected from glycaemia
from early release of saccharides. The resulting en-
hanced GIP secretion would induce insulin secretion, as
Table 5 A comparison of the glycaemic responses of the high
and low amylase subjects to carbohydrate tolerance tests
LA group HA group p value
(n = 5) (n = 5)
AUC (glucose) 363 ± 115 329 ± 103 0.635
AUC (maltose) 302 ± 50 324 ± 40 0.458
AUC (starch) 267 ± 64 159 ± 72 0.037*
P values were calculated using independent t-tests
LA low amylase subjects
HA high-amylase subjects
(AUC = area under the blood glucose curve. AUC values are presented as
mmol/L*120 min). Data are presented as mean ± SD
Fig. 3 Glycaemic responses of the high (HA, n = 5) and low amylase (LA, n = 5) subjects to boluses of starch (upper graph), maltose and glucose
(lower graph). The subjects’ averaged glycaemic responses to glucose are presented (vertical bars = +/− SD)
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Fig. 4 A potential rationale for why the glycaemic response of high salivary amylase secretors is less than that of low salivary amylase secretors
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a rapid and effective gastrointestinal anticipatory re-
sponse, as found for the HA group in our present study.
It is interesting to note that the evidence for the asso-
ciation between salivary amylase activity and obesity is
currently inconclusive. While there is data to suggest
that low copy number of AMY1 was correlated with
obesity [22–24], there is also evidence to the contrary
[25]. As obesity is well-known to be associated with im-
paired glucose tolerance, the former finding is consistent
with the data which we have reported in the present
paper. In short, previous reports suggest that the glucose
tolerance of individuals secreting a low activity of saliv-
ary amylase is likely to be impaired when compared to
the glucose tolerance of individuals who are high amyl-
ase secretors. Whether the difference in BMI between
the high- and low-salivary amylase producers seen in
our study may have contributed to our results is not cer-
tain, because of the small size of our experimental
groups. In our cohort of 54 subjects, we found no cor-
relation between BMI and salivary amylase concentra-
tion or secretory rate, as in all comparisons p > 0.3.
Never-the-less this data have to be interpreted with cau-
tion, because one of the inclusion criteria for our sub-
jects in the first part of this study was to have a BMI
between 18 and 27.4 (i.e. to be within the “non-obese”
range for Asians). Moreover, the lack of a significant dif-
ference between the LA and HA subjects in their gly-
caemic responses to maltose and glucose, suggests that
the difference seen with starch is not related to BMI, as
otherwise we would have expected to observe it after ad-
ministering boluses of all three carbohydrates.
While a high degree of correlation was observed be-
tween fasting and stimulated salivary flow rates (r = 0.883,
p < 0.001), salivary flow rates increased after stimulation
(0.51(0.34) vs. 0.65(0.39) ml/min). However, the method
used to stimulate saliva in the current study (application
of acetic to the dorsal surface of the tongue) does not
introduce the action of mastication that also influences
salivary flow, as seen for example in Mandel’s study [5].
Hence the effect may not have been as pronounced as the
use of paraffin film to stimulate secretion. However, owing
to cultural acceptance, this method was not used in the
current study. We acknowledge that this could have af-
fected the assessment of salivary amylase activities. The
differences between stimulated and unstimulated amylase
activities require further investigation, as an additional
contributor to variations in glycaemic response to a starch
bolus.
Conclusions
In brief, our results confirm in Asians earlier studies in
American and Chilean Europeans, and show that, after a
starch bolus, glycaemia from starch is lesser in high sal-
ivary amylase secretors, and greater in low salivary
amylase secretors. One plausible explanation for this
seemingly anomalous result is that the potent salivary
amylase, secreted by HA subjects, will induce an early
rise in saccharide production in the proximal part of the
small intestine, that will initiate a rapid “incretin” re-
sponse, mediated via GIP secretion. This explanation
can account for the anomalies in our results for the gly-
caemic response to the digestion of starch, but, requires
further studies to be refuted or validated.
However, whatever the mechanism that underlies the
seemingly anomalous results of our study, it is con-
cluded that low amylase secretion may be a prognostica-
tor for impaired glucose tolerance to dietary starch in
young Malaysian adults. This interesting concept paves
the way for development and evaluation of a simple test
of low salivary amylase, as a predictor of future or
present impaired glycaemic tolerance to starch.
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